Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03181724 · ClinicalTrials.gov registry record · NA

The Effect of Review of a Decision Aid Prior to the Appointment on Decisional Conflict Compared to Usual Care in the Treatment of Trapeziometacarpal (TMC) Arthritis

A NA study of Trapeziometacarpal Arthritis, sponsored by Massachusetts General Hospital.

Completed
Registry status
NA
Development phase
90
Enrollment target
1
Study location

NCT03181724 is a NA study of Trapeziometacarpal Arthritis that has completed, run by Massachusetts General Hospital. The registered enrollment target is 90 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03181724, a NA study of Trapeziometacarpal Arthritis, has completed, sponsored by Massachusetts General Hospital.

COMPLETED
Registry status
NA
Development phase
90 participants
Enrollment target
1
Study location

Study Summary

The investigators plan a prospective randomized controlled study that compares whether the use of a decision aid results in different scores on variables reflective of the decision-making process, behavior, health outcomes, communication, and healthcare system.

Interventions

  • BEHAVIORAL Decision Aid

Study Locations (1)

Massachusetts

  • Massachusetts General Hospital - Boston

Trial Details

FieldValue
Enrollment Target 90 participants
Start Date 2016-05-13
Est. Completion 2017-11
Phase NA

Sponsor

Massachusetts General Hospital

2,032 total trials

What the Registry Record Tells You About NCT03181724

The ClinicalTrials.gov registry entry for NCT03181724 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Trapeziometacarpal Arthritis appearing as the primary indexed condition, and to 1 intervention - of which Decision Aid is the first listed.

NCT03181724 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT03181724 about?

NCT03181724 is a clinical study titled "The Effect of Review of a Decision Aid Prior to the Appointment on Decisional Conflict Compared to Usual Care in the Treatment of Trapeziometacarpal (TMC) Arthritis". The investigators plan a prospective randomized controlled study that compares whether the use of a decision aid results in different scores on variables reflective of the decision-making process, behavior, health outcomes, communication, and healthcare system.

What is the current status of trial NCT03181724?

This trial is currently completed. It is a NA study. The enrollment target is 90 participants. The study started on 2016-05-13. Estimated completion is 2017-11.

What conditions does trial NCT03181724 study?

This clinical trial studies the following conditions: Trapeziometacarpal Arthritis.

What interventions are being tested in trial NCT03181724?

The interventions under investigation include: Decision Aid (BEHAVIORAL).

Who is sponsoring clinical trial NCT03181724?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03181724 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.